Felbamate
- Product NDC
- 51525-0431
- 11-digit product format
- 515250431
- Labeler code
- 51525
- Product ID
- 51525-0431_525ae813-9695-47a8-8f75-9a3abadd3b50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- felbamate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Wallace Pharmaceuticals Inc.
- Application
- NDA020189
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2011-11-11
- Marketing end
- 0000-00-00
- Substance
- FELBAMATE
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51525-0431 | FELBAMATE TABLET FELBAMATE SUSPENSION [WALLACE PHARMACEUTICALS INC.] | 9 | Legacy NDC | 20250312_c0c15d60-1171-11e1-9be0-0002a5d5c51b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51525-0431-1 | 51525043101 | 100 TABLET in 1 BOTTLE (51525-0431-1) | 100 tablet | 2011-11-11 | 0000-00-00 | No | No | Current |